Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
May 24, 2023
Going long: Viruses linger with lasting impact
Herpes, HIV, Epstein-Barr and other viruses hang around, causing potential long-term health woes. Should ‘long COVID’ surprise us?
Fred Hutch leads large-scale review of COVID-19 clinical trials that highlights multiple disparities
Meta-analysis of 122 COVID-19 clinical trials cites need for strategies to address trial participation gaps
Tackling the unknowns of long-haul COVID-19
Fred Hutch and UW researchers are working together to better understand and treat the syndrome
Hopes and predictions for 2022
Hutch researchers look ahead to an increase in cancer screening, improved vaccines and greater trust in science
Science Says: Fearless science
Immunotherapy, equity in colorectal cancer and the latest on the COVID-19 virus's omicron variant
Using AI to identify potential COVID-19, cancer therapies
Early findings show current drugs might be repurposed to calm COVID-19’s cytokine storms, treat metastatic prostate cancer
Ongoing trials test COVID-19 drugs for earlier, easier treatment
Injected monoclonal antibodies or oral antivirals could help more patients recover faster
Addressing a 'massive unmet need' in COVID-19 treatment
COVID-19 Clinical Research Center tests drugs to reduce severe infections
Tip Sheet: Latest research on COVID-19, health disparities, antibodies to parainfluenza, and neuron function
Summaries of recent Fred Hutch research findings and other news
Fred Hutch opens COVID-19 Clinical Research Center
Medical director outlines goals for the new facility that will host two treatment trials right away
Fred Hutch opens COVID-19 Clinical Research Center
Newly renovated facility is among the first stand-alone centers specifically designed to test novel interventions such as monoclonal antibodies and antivirals to treat and prevent COVID-19
When COVID-19 crosses paths with HIV
Survivors of one pandemic now brace for a new one
HIV status among patients at the Uganda Cancer Institute
From the Global Oncology program, Vaccine and Infectious Disease Division